Kang Hee-Jun, Kim Sang-Won, Kim Seon-Myung, La Tae-Min, Hyun Jae-Eun, Lee Sang-Won, Kim Jung-Hyun
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea.
KR Lab Bio Incorporation, Suwon 16429, Republic of Korea.
Animals (Basel). 2024 Oct 7;14(19):2883. doi: 10.3390/ani14192883.
Hyperadrenocorticism (HAC) is a common endocrine disorder in dogs, which is associated with diverse metabolic abnormalities. We hypothesized that elevated cortisol levels in dogs with HAC disrupt the gut microbiome (GM), and this disruption persists even after trilostane treatment. This study explored GM composition in dogs with HAC. We included 24 dogs, 15 with HAC and 9 healthy controls, and followed up with 5 dogs with HAC who received trilostane treatment. The GM analysis revealed significant compositional changes in dogs with HAC, including reduced microbiome diversity compared to healthy controls, particularly in rare taxa, as indicated by the Shannon index ( = 0.0148). Beta diversity analysis further showed a distinct clustering of microbiomes in dogs with HAC, separating them from healthy dogs ( < 0.003). Specifically, an overrepresentation of Proteobacteria (Pseudomonadota), Actinobacteria, , , , , and populations occurred alongside a decreased Firmicutes (Bacillota) population. Despite trilostane treatment, gut dysbiosis persisted in dogs with HAC at a median of 41 d post treatment, suggesting its potential role in ongoing metabolic issues. We identified GM dysbiosis in dogs with HAC by examining key bacterial genera, offering insights into potential interventions like probiotics or fecal microbiota transplants for better HAC management.
肾上腺皮质功能亢进(HAC)是犬类常见的内分泌疾病,与多种代谢异常有关。我们推测,患有HAC的犬只体内皮质醇水平升高会破坏肠道微生物群(GM),而且即使在曲洛司坦治疗后,这种破坏仍会持续。本研究探讨了患有HAC的犬只的GM组成。我们纳入了24只犬,其中15只患有HAC,9只为健康对照,并对5只接受曲洛司坦治疗的患有HAC的犬只进行了随访。GM分析显示,患有HAC的犬只存在显著的组成变化,与健康对照相比,微生物群多样性降低,尤其是在稀有分类群中,如香农指数所示(=0.0148)。β多样性分析进一步表明,患有HAC的犬只的微生物群有明显的聚类,与健康犬只区分开来(<0.003)。具体而言,变形菌门(假单胞菌门)、放线菌门、、、、和种群的过度代表与厚壁菌门(芽孢杆菌门)种群的减少同时出现。尽管进行了曲洛司坦治疗,但患有HAC的犬只在治疗后中位数41天时肠道菌群失调仍然存在,这表明其在持续的代谢问题中可能发挥作用。我们通过检查关键细菌属,确定了患有HAC的犬只存在GM失调,这为益生菌或粪便微生物群移植等潜在干预措施提供了见解,以便更好地管理HAC。